Israeli genetics experts devise groundbreaking fetal test, and Israel’s Kyma Medical Technologies has developed a device to monitor fluids in the lungs – an early sign of congestive heart failure.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
Groundbreaking fetal test
Genetics experts at Jerusalem’s Shaare Zedek Medical Center have devised a patent-pending process to screen a fetus for genetic diseases using a blood sample from the mother. It is the first that can detect genetic mutations from both the father and mother’s DNA.
Monitoring for heart failure
Israel’s Kyma Medical Technologies has developed a radio frequency-based technology device to monitor fluids in the lungs – an early sign of congestive heart failure. Kyma has just been acquired by US medical device company ZOLL for a minimum of $35 million.
Oral proteins get US patent
The United States Patent and Trademark Office has approved a patent from Israel’s Oramed for its invention, titled “Methods and Compositions for Oral Administrations of Proteins.” The patent is the basis for Oramed’s ORMD-0801 oral insulin for the early treatment of types 1 and 2 diabetes.
Find the best hospital for your procedure
Israeli entrepreneur Moni Milchman has developed ArchimedicX, the world’s first search engine that rates hospitals by procedure. Its criteria includes results and repeat treatment statistics, budget, staff quality, reputation, beds per room, waiting time, language, food quality and much more.
US launch of stress-management supplement
US-based Jarrow Formulas has launched its supplement PS-PA Synergy, which is based on Lipogen PSPA, developed by Israel’s Lipogen. Lipogen PSPA has been clinically shown to alleviate stress response and improve cognition.
New Jersey-Israel health foods alliance
Rutgers University in New Jersey, Tel Hai College in Upper Galilee, and the Israeli Knesset signed a memorandum of understanding to launch the New Jersey-Israel Healthy, Functional and Medical Foods Alliance. It will research and commercialize disease-preventing foods.
US Navy buys Israeli brain therapy system
The UN Navy has ordered several Deep TMS therapy helmets made by Israel’s Brainsway. Deep Transcranial Magnetic Stimulation will treat service personnel with a range of psychological conditions, including post-traumatic stress disorder (PTSD) and major depressive disorder.
Click here for all of this week’s Good News from Israel.
Source: United with Israel